Search Results - "Gaffar, Md. Abu Jar"

Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study) by Saifuddin, Mohammad, Paul, Ajit K., Shefin, Sultana M., Alam, Md. Jahangir, Selim, Shahjada, Islam, Sunjida, Hossain, Tanjina, Tuqan, Sadiqa, Sultana, Nusrat, Mustari, Marufa, Basak, Ramen C., Aftab, Kazi A., Prasad, Indrajit, Uddin, Mohammad R., Sharker, Shoma, Gaffar, Md. Abu Jar, Rahman, Mohammad M., Hannan, Mohammad A., Ahammed, Afsar, Kamrul-Hasan, ABM

“…Background: Empagliflozin is a relatively newer glucose-lowering drug (GLD) with many extra-glycemic benefits. To date, no study has evaluated the efficacy and…”
Get full text

Insulin Injection Practice and Injection Complications - Results from the Bangladesh Insulin Injection Technique Survey by Kamrul-Hasan, Abm, Paul, Ajit Kumar, Amin, Mohammad Nurul, Gaffar, Md Abu Jar, Asaduzzaman, Md, Saifuddin, Mohammad, Mustari, Marufa, Alam, Md Jahangir, Shahid, Mohammad Moin, Nahid-Ul-Haque, K M, Alam, Muhammad Shah, Rahman, Md Motiur, Talukder, Samir Kumar, Kader, Md Abdul, Akter, Farhana, Hannan, Mohammad Abdul, Chanda, Palash Kumar, Bakar, Muhammed Abu, Selim, Shahjada

“…INTRODUCTIONDiabetes mellitus is highly prevalent in Bangladesh and insulin is often needed for diabetes control. We lack sufficient data on the insulin…”
Get full text

Evaluation of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as markers of diabetic kidney disease in Bangladeshi patients with type 2 diabetes mellitus by Kamrul-Hasan, A, Mustari, Marufa, Asaduzzaman, Md, Gaffar, Md, Chanda, Palash, Rahman, Mohammad, Hannan, Mohammad, Akter, Farhana, Saifuddin, Mohammad, Selim, Shahjada

Get full text